DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma

Immune checkpoint inhibitors(ICIs) that activate tumor-specific immune responses bring new hope for the treatment of hepatocellular carcinoma(HCC). However, there are still some problems, such as uncertain curative effects and low objective response rates, which limit the curative effect of immunoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yunfei, Wang, Xu, Deng, Xiaofan, Zhang, Yu, Liao, Rui, Li, Youzan, Yang, Hongji, Chen, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320764/
https://www.ncbi.nlm.nih.gov/pubmed/34335575
http://dx.doi.org/10.3389/fimmu.2021.676922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320764/
https://www.ncbi.nlm.nih.gov/pubmed/34335575
http://dx.doi.org/10.3389/fimmu.2021.676922

Ejemplares similares